JPMorgan Chase & Co. Sells 119,903 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

JPMorgan Chase & Co. decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 15.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 659,274 shares of the medical instruments supplier's stock after selling 119,903 shares during the quarter. JPMorgan Chase & Co. owned 2.69% of ICU Medical worth $120,133,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Victory Capital Management Inc. raised its position in ICU Medical by 2,966.3% in the second quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier's stock valued at $16,844,000 after purchasing an additional 137,222 shares during the last quarter. Millennium Management LLC boosted its position in ICU Medical by 327.8% during the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier's stock worth $16,158,000 after buying an additional 104,264 shares during the period. FMR LLC grew its holdings in ICU Medical by 2,676.6% during the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after acquiring an additional 100,345 shares during the last quarter. Granite Investment Partners LLC acquired a new position in ICU Medical in the 2nd quarter valued at approximately $10,650,000. Finally, State Street Corp raised its stake in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after acquiring an additional 77,506 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Trading Up 1.8 %

ICUI stock traded up $2.81 during mid-day trading on Thursday, reaching $157.98. The company's stock had a trading volume of 208,164 shares, compared to its average volume of 269,089. ICU Medical, Inc. has a 12 month low of $86.80 and a 12 month high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The business's 50 day moving average price is $164.56 and its 200 day moving average price is $155.51. The company has a market cap of $3.87 billion, a price-to-earnings ratio of -34.57 and a beta of 0.62.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ICUI. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. Raymond James increased their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. Finally, KeyCorp upped their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, ICU Medical presently has a consensus rating of "Moderate Buy" and a consensus price target of $199.67.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Friday, November 1st. The shares were sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $17,973,261.12. The trade was a 10.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David C. Greenberg sold 972 shares of the company's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the completion of the sale, the director now directly owns 5,037 shares of the company's stock, valued at $796,400.07. The trade was a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 29,737 shares of company stock worth $4,941,832 in the last quarter. Company insiders own 6.70% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.